Cervicovaginal fluid cytokines as predictive markers of preterm birth in symptomatic women.

Biomarkers Cytokines Interleukin-17A Interleukin-6 Preterm birth

Journal

Obstetrics & gynecology science
ISSN: 2287-8572
Titre abrégé: Obstet Gynecol Sci
Pays: Korea (South)
ID NLM: 101602614

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 26 07 2019
accepted: 15 04 2020
pubmed: 20 6 2020
medline: 20 6 2020
entrez: 20 6 2020
Statut: ppublish

Résumé

Here, we investigated whether cytokines in the cervicovaginal fluid (CVF) can be predictive markers of preterm birth (PTB). A multi-center prospective cohort study was conducted on 59 singleton pregnant women hospitalized for preterm labor (PTL) and/or preterm premature rupture of membranes (pPROM) between 22 weeks and 36 weeks 6 days of gestation from 2014 to 2015. The levels of 13 inflammatory cytokines (macrophage inflammatory protein [MIP]-1α, MIP-1β, tumor necrosis factor [TNF]-α, interleukin [IL]-1β, IL-6, IL-8, IL-17α, granulocyte colony stimulating factor [G-CSF], IL-7, IL-4, IL-5, IL-10, and IL-13) were measured using a multiplex bead-based immunoassay and that of fetal fibronectin (fFN) was measured using enzyme-linked immunosorbent assay (ELISA). Statistical analyses were performed using Student's t-test, Mann-Whitney U test, Pearson's correlation, and receiver operating characteristic (ROC) curve analysis in SPSS version 20.0. Among the 13 cytokines assessed, the levels of 3 cytokines (MIP-1α, IL-6, and IL-7) were negatively correlated with gestational age at delivery (P=0.028, P=0.002, and P=0.018, respectively). Sensitivities of MIP-1α, IL-6, and IL-17α were 70%, 80%, and 75%, respectively, and their specificities were 57%, 65%, and 69%, respectively. The sensitivity and specificity of fFN were 33% and 95%, respectively. In symptomatic women diagnosed with PTL and/or pPROM, cytokines from cervicovaginal fluid, especially IL-6 and IL-17α, could be better predictive markers of PTB than fFN.

Identifiants

pubmed: 32550740
pii: ogs.19131
doi: 10.5468/ogs.19131
pmc: PMC7393743
doi:

Types de publication

Journal Article

Langues

eng

Pagination

455-463

Subventions

Organisme : Ministry of Health and Welfare
ID : HI18C0378
Organisme : Korea Health Industry Development Institute

Références

Am J Reprod Immunol. 2016 Feb;75(2):155-61
pubmed: 26589553
Front Physiol. 2015 May 13;6:151
pubmed: 26029118
Obstet Gynecol Sci. 2018 Sep;61(5):565-574
pubmed: 30254992
N Engl J Med. 1991 Sep 5;325(10):669-74
pubmed: 1870640
J Obstet Gynaecol Res. 2016 Jul;42(7):776-83
pubmed: 26990253
Adv Appl Microbiol. 2012;80:1-22
pubmed: 22794142
J Reprod Immunol. 2018 Apr;126:1-10
pubmed: 29367099
Am J Obstet Gynecol. 1998 Sep;179(3 Pt 1):644-9
pubmed: 9757965
Int J Gynaecol Obstet. 2003 Nov;83(2):151-7
pubmed: 14550589
BJOG. 2011 Aug;118(9):1042-54
pubmed: 21401853
J Matern Fetal Neonatal Med. 2018 Jan;31(2):228-244
pubmed: 28081646
Eur J Obstet Gynecol Reprod Biol. 2001 Apr;95(2):154-8
pubmed: 11301160
J Matern Fetal Neonatal Med. 2012 Aug;25(8):1428-32
pubmed: 22098613
Am J Obstet Gynecol. 2008 Dec;199(6):656.e1-7
pubmed: 18640661
Gynecol Endocrinol. 2017 May;33(5):408-412
pubmed: 28277132
J Matern Fetal Neonatal Med. 2015 Jan;28(2):134-40
pubmed: 24670234
AJP Rep. 2018 Apr;8(2):e113-e120
pubmed: 29868246
J Infect Dis. 1982 Jan;145(1):1-8
pubmed: 7033397
BJOG. 2003 Jun;110(6):598-603
pubmed: 12798479
PLoS One. 2012;7(7):e39154
pubmed: 22815699
PLoS One. 2012;7(12):e52412
pubmed: 23300664
Semin Perinatol. 2017 Dec;41(8):445-451
pubmed: 28935263
Am J Obstet Gynecol. 1996 Oct;175(4 Pt 1):812-7
pubmed: 8885727
Gynecol Obstet Invest. 2005;60(4):206-12
pubmed: 16088197
Obstet Gynecol Sci. 2018 Jan;61(1):38-47
pubmed: 29372148
J Reprod Immunol. 2008 Apr;77(2):152-60
pubmed: 17692390
Eur J Obstet Gynecol Reprod Biol. 2018 Dec;231:235-240
pubmed: 30439652
BJOG. 2015 Feb;122(3):370-9
pubmed: 25056135
Acta Obstet Gynecol Scand. 2001 Jun;80(6):546-51
pubmed: 11380291
Acta Obstet Gynecol Scand. 2007;86(2):151-5
pubmed: 17364276
Biomed Res Int. 2014;2014:164081
pubmed: 24551837
Am J Obstet Gynecol. 2001 Sep;185(3):643-51
pubmed: 11568793
PLoS One. 2018 Jul 6;13(7):e0200311
pubmed: 29979758
Am J Reprod Immunol. 1994 Sep;32(2):108-13
pubmed: 7826499
Am J Obstet Gynecol. 2013 Mar;208(3):233.e1-6
pubmed: 23246314
Am J Obstet Gynecol. 2016 Feb;214(2):276.e1-276.e6
pubmed: 26364833
BJOG. 2003 Apr;110 Suppl 20:66-70
pubmed: 12763115
Am J Obstet Gynecol. 2016 Jul 9;:
pubmed: 27403846

Auteurs

Sunwha Park (S)

Department of Obstetrics and Gynecology, Ewha Womans University Mokdong Hospital, Seoul, Korea.

Young-Ah You (YA)

Ewha Medical Research Institute, College of Medicine, Ewha Womans University, Seoul, Korea.

Hayoung Yun (H)

Department of Obstetrics and Gynecology, Ewha Womans University Mokdong Hospital, Seoul, Korea.

Suk-Joo Choi (SJ)

Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Han-Sung Hwang (HS)

Department of Obstetrics and Gynecology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.

Sae-Kyung Choi (SK)

Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Seung Mi Lee (SM)

Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.

Young Ju Kim (YJ)

Department of Obstetrics and Gynecology, Ewha Womans University Mokdong Hospital, Seoul, Korea.
Ewha Medical Research Institute, College of Medicine, Ewha Womans University, Seoul, Korea.

Classifications MeSH